UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 95.335
NA - Nord America 4.663
AS - Asia 1.964
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 80
OC - Oceania 4
Totale 102.510
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 94.190
US - Stati Uniti d'America 4.522
SG - Singapore 728
CN - Cina 591
SE - Svezia 281
VN - Vietnam 214
BR - Brasile 198
DE - Germania 184
UA - Ucraina 148
GB - Regno Unito 130
FI - Finlandia 117
FR - Francia 86
CA - Canada 81
BD - Bangladesh 77
HK - Hong Kong 60
IN - India 43
TR - Turchia 41
KR - Corea 37
ZA - Sudafrica 32
NL - Olanda 28
PL - Polonia 26
IQ - Iraq 24
AR - Argentina 23
RU - Federazione Russa 22
BE - Belgio 21
JP - Giappone 19
MA - Marocco 19
IR - Iran 18
MX - Messico 17
ES - Italia 15
PK - Pakistan 15
AT - Austria 14
LT - Lituania 12
IE - Irlanda 11
JO - Giordania 11
CO - Colombia 10
EC - Ecuador 10
MY - Malesia 9
CH - Svizzera 8
HN - Honduras 8
ID - Indonesia 8
IL - Israele 8
PH - Filippine 7
UZ - Uzbekistan 7
VE - Venezuela 7
JM - Giamaica 6
PR - Porto Rico 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DK - Danimarca 5
EG - Egitto 5
MT - Malta 5
PE - Perù 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
EE - Estonia 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
PA - Panama 4
PT - Portogallo 4
AU - Australia 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
SC - Seychelles 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GH - Ghana 1
Totale 102.298
Salva come PNG Salva come JPEG
Città #
Cagliari 92.229
Uta 1.594
Ashburn 613
Singapore 456
Fairfield 328
San Jose 322
Woodbridge 216
Chandler 202
Nyköping 180
Boardman 171
Los Angeles 168
Houston 162
Ann Arbor 150
Beijing 130
Seattle 124
Dallas 120
Wilmington 116
Cambridge 106
Council Bluffs 93
Santa Clara 86
New York 84
Dearborn 82
Helsinki 79
Jacksonville 65
The Dalles 65
Hong Kong 57
Hanoi 49
Ho Chi Minh City 48
Shanghai 45
Lauterbourg 44
Hefei 42
Nanjing 31
Seoul 31
Frankfurt am Main 29
Milan 29
Dong Ket 28
London 28
Buffalo 27
São Paulo 26
Munich 25
Rome 24
Chicago 23
Columbus 23
Redwood City 23
Warsaw 23
Boston 22
Toronto 22
Brussels 20
Montreal 20
Johannesburg 19
Kocaeli 19
Phoenix 19
San Diego 19
San Mateo 19
Atlanta 18
Guangzhou 18
Stockholm 17
Denver 16
Orem 16
Redondo Beach 16
Chennai 15
Casablanca 13
Da Nang 13
Pisa 13
Amsterdam 12
Brooklyn 12
Falls Church 12
Haiphong 12
Nuremberg 12
Turku 12
Jiaxing 11
Mountain View 11
Amman 10
Bari 10
Nanchang 10
Tokyo 10
Changsha 9
Dublin 9
Naples 9
Norwalk 9
Rio de Janeiro 9
Vienna 9
Baghdad 8
Dhaka 8
Florence 8
Manchester 8
Shenyang 8
Shenzhen 8
Tianjin 8
Washington 8
Augusta 7
Biên Hòa 7
Bogazici 7
Düsseldorf 7
Leawood 7
Milwaukee 7
Poplar 7
Pune 7
Turin 7
Auburn Hills 6
Totale 99.251
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.034
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.988
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.288
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.265
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.087
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.983
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.904
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.784
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.741
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.693
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.602
Global gene expression profile of normal and regenerating liver in young and old mice 3.588
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.533
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.228
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.191
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.114
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.777
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.663
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.396
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.371
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.345
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.150
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.053
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.691
Early metabolic changes in a liver carcinogenesis model 1.523
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.480
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.475
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.238
Early Metabolic Changes in preneoplastc nodules of the liver 1.210
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 991
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 988
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 936
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 902
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 901
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 869
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 865
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 765
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 727
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 687
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 635
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 547
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 545
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 497
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 495
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 452
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 450
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 449
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 414
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 361
Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model 222
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 165
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 144
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 77
Mapping the Binding Landscape of Allosteric Inhibitor G6PDi-1 on Human G6PD 31
Totale 102.510
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.630 0 0 0 0 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202521.115 7.396 7.556 1.492 1.484 689 893 981 78 128 125 130 163
2025/20264.799 349 205 343 374 451 302 1.250 249 263 534 310 169
2026/20271.248 172 265 312 488 11 0 0 0 0 0 0 0
Totale 102.510